Post Ads
Messages (0)
View All
- Message not found

T-DXd Improves Invasive DFS vs T-DM1 in HER2+ Early Breast Cancer Subgroup

5 months ago | By: CancerNetwork

T-DXd Improves Invasive DFS vs T-DM1 in HER2+ Early Breast Cancer Subgroup

description

Fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) improved invasive disease-free survival (IDFS) compared with trastuzumab emtansine (T-DM1; Kadcyla) as treatment for patients with HER2-positive early breast cancer with residual invasive disease in th... [4111 chars].. reed more

(8)preview (8)click

Post your Blog Click here

Category

Recent news

Power the AI-first retail revolution with Lenovo's Solutions & Services Group

Power the AI-first retail revolution with Lenovo's Solutions & Services Group

13 hours ago

Benjani Mwaruwari on cloud nine after maintaining Highlanders' unbeaten run against Dynamos

Benjani Mwaruwari on cloud nine after maintaining Highlanders' unbeaten run against Dynamos

12 hours ago

OnePlus Nord 6 Tipped to Have Same Specifications as China-exclusive OnePlus Turbo 6; May Launch in April

OnePlus Nord 6 Tipped to Have Same Specifications as China-exclusive OnePlus Turbo 6; May Launch in April

12 hours ago

Sudden Sight Loss Risk Almost 5x Higher With Wegovy Than Ozempic, Study Finds

Sudden Sight Loss Risk Almost 5x Higher With Wegovy Than Ozempic, Study Finds

12 hours ago

Severe flooding kills 66 in Kenya, as heavy rains continue

Severe flooding kills 66 in Kenya, as heavy rains continue

13 hours ago

Trump's ill-fated attempt to copy Israel's 'mowing the grass' strategy

Trump's ill-fated attempt to copy Israel's 'mowing the grass' strategy

13 hours ago